Epidemiology and management of chronic kidney disease in South Asians

南亚人慢性肾脏病的流行病学和治疗

基本信息

  • 批准号:
    8679738
  • 负责人:
  • 金额:
    $ 17.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The primary purpose of this proposal is to provide mentored guidance for Dr. Shuchi Anand as she becomes an independent clinician researcher. Dr. Anand is interested in kidney disease care in a global health context, particularly in highlighting the growing burden of chronic kidney disease (CKD) in low- and middle-income countries and in devising innovative strategies to manage CKD. Thus this proposal will study the epidemiology of CKD in South Asians and evaluate low-cost tools for its management in patients with diabetes. South Asians have recently been identified to be at high risk for insulin resistance in the form of diabetes and metabolic syndrome, with a four-fold higher prevalence and two-fold higher incidence of diabetes than U.S. whites. Yet limited data are available on one of the most important end-organ consequences, i.e., CKD. This proposal uses data from the Cardiometabolic Risk Reduction in South Asia (CARRS) study, a community-based cohort of adults living in New Delhi, Chennai, and Karachi to study the prevalence and incidence of CKD, with the hypothesis that insulin resistance will be the primary risk factor for CKD even among South Asians living in a resource-constrained setting. To evaluate the extent to which management of risk factors such as blood glucose and blood pressure plays a role in determining the burden of CKD, the study will compare CKD prevalence in CARRS with CKD prevalence in South Asians living in the U.S. (where risk factors are expected to be better managed). A pooled dataset will be created from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study and the Pan Asian Cohort (PAC) Research Database to perform this analysis. In addition the study will explore which markers of body size (waist-circumference, waist-to-hip ratio, or body mass index) and of insulin resistance (fasting glucose, hemoglobin a1c, or fasting insulin levels) best predict new onset CKD among South Asians. The final aim of this proposal is to create a sub-study within an ongoing randomized control trial in five sites in rural India. The sub-study will evaluate a structured education intervention by a lay health worker in motivating patients with diabetes to seek care after undergoing a screening urine dipstick, which will be used as a tool to identify high risk (proteinuric) patients as well a to discuss the end-organ consequences of diabetes. A qualitative survey of patients and providers will also be performed to identify barriers to care. The overall goal is to report on the burden of CKD among South Asians and attempt to manage it with low-cost strategies. With this proposal, Dr. Anand will advance her epidemiology skills by working on analyses from the CARRS, MASALA, and PAC databases. She will obtain additional training in health services research via didactic coursework and on-the-ground project implementation. Throughout the process, she will receive training and guidance from experts in global health, nephrology, health policy, and biostatistics as she builds a strong foundation for a productive research career.
描述(由申请人提供):本提案的主要目的是为 Shuchi Anand 博士成为一名独立临床研究员提供指导。 Anand 博士对全球健康背景下的肾脏疾病护理感兴趣,特别是强调低收入和中等收入国家慢性肾脏病 (CKD) 日益沉重的负担,并制定管理 CKD 的创新策略。因此,该提案将研究南亚人 CKD 的流行病学,并评估糖尿病患者管理的低成本工具。最近发现,南亚人患糖尿病和代谢综合征等胰岛素抵抗的风险较高,其患病率和发病率是美国白人的四倍和两倍。然而,关于最重要的终末器官后果之一(即 CKD)的可用数据有限。该提案使用了南亚心脏代谢风险降低 (CARRS) 研究的数据,该研究是一项居住在新德里、钦奈和卡拉奇的社区成年人队列研究,旨在研究 CKD 的患病率和发病率,并假设胰岛素抵抗将即使对于生活在资源有限环境中的南亚人来说,这也是 CKD 的主要危险因素。为了评估血糖和血压等危险因素的管理在确定 CKD 负担方面发挥的作用程度,该研究将比较 CARRS 中的 CKD 患病率与居住在美国的南亚人的 CKD 患病率(其中危险因素为预计会得到更好的管理)。居住在美国的南亚人动脉粥样硬化调节因子 (MASALA) 研究和泛亚队列 (PAC) 研究数据库将创建一个汇总数据集来执行此分析。此外,该研究还将探讨哪些身体尺寸标志物(腰围、腰臀比或体重指数)和胰岛素抵抗标志物(空腹血糖、血红蛋白 a1c 或空腹胰岛素水平)最能预测新发 CKD南亚人。该提案的最终目标是在印度农村五个地点正在进行的随机对照试验中创建一项子研究。该子研究将评估由非专业人士进行的结构化教育干预 卫生工作者激励糖尿病患者在接受尿液试纸筛查后寻求护理,尿液试纸将用作识别高风险(蛋白尿)患者以及讨论糖尿病的终末器官后果的工具。还将对患者和提供者进行定性调查,以确定护理障碍。总体目标是报告负担 南亚人患有慢性肾病,并尝试通过低成本策略进行管理。通过这项提案,Anand 博士将通过对 CARRS、MASALA 和 PAC 数据库进行分析来提高她的流行病学技能。她将通过教学课程和实地项目实施获得卫生服务研究方面的额外培训。在整个过程中,她将接受全球健康、肾病学、卫生政策和生物统计学专家的培训和指导,为她富有成效的研究生涯奠定坚实的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shuchi Anand其他文献

Shuchi Anand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shuchi Anand', 18)}}的其他基金

Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
美国服务不足人群的流行病防范:利用 RADx-UP 联盟的数据评估用于资源分配的公共卫生工具
  • 批准号:
    10881319
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
透析设施中的 SARS-COV-2 筛查:制定保护高危人群的最佳策略
  • 批准号:
    10447527
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
SARS-COV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect High Risk Populations
透析设施中的 SARS-COV-2 筛查:制定保护高危人群的最佳策略
  • 批准号:
    10549372
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
病因不明的慢性肾病:应用多学科方法研究世界上最常见的肾小管间质性肾病
  • 批准号:
    10561691
  • 财政年份:
    2021
  • 资助金额:
    $ 17.89万
  • 项目类别:
Epidemiology and management of chronic kidney disease in South Asians
南亚人慢性肾脏病的流行病学和治疗
  • 批准号:
    8916107
  • 财政年份:
    2014
  • 资助金额:
    $ 17.89万
  • 项目类别:
Self reproted physical activity in the dialysis population
透析人群的自我报告体力活动
  • 批准号:
    7753523
  • 财政年份:
    2009
  • 资助金额:
    $ 17.89万
  • 项目类别:
Self reproted physical activity in the dialysis population
透析人群的自我报告体力活动
  • 批准号:
    8044170
  • 财政年份:
    2009
  • 资助金额:
    $ 17.89万
  • 项目类别:

相似国自然基金

基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
  • 批准号:
    82304256
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
  • 批准号:
    72304279
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
  • 批准号:
    82373638
  • 批准年份:
    2023
  • 资助金额:
    59 万元
  • 项目类别:
    面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
  • 批准号:
    72304180
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Siyaphambili Substance Use Study: Exploring substance use and its treatment in the context of achieving sustained ART adherence among female sex workers
Siyaphambili 物质使用研究:在女性性工作者实现持续 ART 坚持的背景下探索物质使用及其治疗
  • 批准号:
    10619245
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
A multi-site feasibility clinical trial of Retraining and Control Therapy (ReACT), a mind and body treatment for pediatric functional seizures
再训练和控制疗法 (ReACT) 的多中心可行性临床试验,这是一种针对儿童功能性癫痫发作的身心治疗方法
  • 批准号:
    10648379
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Amino Acids and Pediatric Hepatic Steatosis
氨基酸和小儿脂肪肝
  • 批准号:
    10747273
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults
扎马拉:赞比亚知情、积极、有意识、负责任的青少年和成年人
  • 批准号:
    10749138
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Pre-exposure prophylaxis (PrEP) information on social media
社交媒体上的暴露前预防 (PrEP) 信息
  • 批准号:
    10619946
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了